Works matching IS 17762596 AND DT 2014 AND VI 9 AND IP 3

Results: 11
    1
    2
    3
    4
    5
    6
    7
    8

    Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

    Published in:
    Targeted Oncology, 2014, v. 9, n. 3, p. 273, doi. 10.1007/s11523-013-0299-0
    By:
    • Penel, Nicolas;
    • Ray-Coquard, Isabelle;
    • Bal-Mahieu, Christine;
    • Chevreau, Christine;
    • Cesne, Axel;
    • Italiano, Antoine;
    • Bompas, Emmanuelle;
    • Clisant, Stéphanie;
    • Baldeyrou, Brigitte;
    • Lansiaux, Amélie;
    • Robin, Yves-Marie;
    • Bay, Jacques-Olivier;
    • Piperno-Neumann, Sophie;
    • Blay, Jean-Yves;
    • Fournier, Charles
    Publication type:
    Article
    9

    New agents in renal cell carcinoma.

    Published in:
    Targeted Oncology, 2014, v. 9, n. 3, p. 183, doi. 10.1007/s11523-013-0303-8
    By:
    • Dabney, Raetasha;
    • Devine, Ryan;
    • Sein, Nancy;
    • George, Benjamin
    Publication type:
    Article
    10
    11

    EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan.

    Published in:
    Targeted Oncology, 2014, v. 9, n. 3, p. 205, doi. 10.1007/s11523-013-0284-7
    By:
    • Loupakis, Fotios;
    • Cremolini, Chiara;
    • Fioravanti, Anna;
    • Orlandi, Paola;
    • Salvatore, Lisa;
    • Masi, Gianluca;
    • Schirripa, Marta;
    • Di Desidero, Teresa;
    • Antoniotti, Carlotta;
    • Canu, Bastianina;
    • Faviana, Pinuccia;
    • Sensi, Elisa;
    • Lupi, Cristiana;
    • Fontanini, Gabriella;
    • Basolo, Fulvio;
    • Di Paolo, Antonello;
    • Danesi, Romano;
    • Falcone, Alfredo;
    • Bocci, Guido
    Publication type:
    Article